Question 1

What’s the financial overview for The United Laboratories International Holdings Limited?

Accepted Answer

The United Laboratories International Holdings Limited’s market cap stands at $0.003 trillion right now. The company’s trailing twelve-month earnings per share EPS is $0.20, with a dividend yield of 1.52%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does The United Laboratories International Holdings Limited Stock ROE tell us?

Accepted Answer

The United Laboratories International Holdings Limited stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for The United Laboratories International Holdings Limited?

Accepted Answer

The The United Laboratories International Holdings Limited stock per share price is $1.85.

Metric	Q4 2024	Q2 2024	Q4 2023	Q2 2023
Revenue	$6.58B	$7.18B	$6.83B	$6.91B
Cost of Revenue	$3.85B	$3.83B	$3.71B	$3.69B
Gross Profit	$2.74B	$3.34B	$3.12B	$3.21B
Gross Profit Ratio	$0.42	$0.47	$0.46	$0.47
R&D Expenses	$443.96M	$446.80M	$418.57M	$338.68M
SG&A Expenses	$1.24B	$1.10B	$1.02B	$1.37B
Operating Expenses	$1.69B	$1.55B	$1.44B	$1.61B
Total Costs & Expenses	$5.53B	$5.38B	$5.15B	$5.31B
Interest Income	$0.00	$0.00	$25.82M	$12.70M
Interest Expense	$0.00	$0.00	$0.00	$0.00
Depreciation & Amortization	$240.95M	$297.06M	$240.58M	$297.43M
EBITDA	$1.34B	$2.01B	$1.91B	$1.80B
EBITDA Ratio	$0.20	$0.28	$0.28	$0.26
Operating Income	$1.05B	$1.80B	$1.68B	$1.50B
Operating Income Ratio	$0.16	$0.25	$0.25	$0.22
Other Income/Expenses (Net)	$335.25M	$103.49M	$49.62M	$106.21M
Income Before Tax	$1.39B	$1.90B	$1.73B	$1.61B
Income Before Tax Ratio	$0.21	$0.27	$0.25	$0.23
Income Tax Expense	$220.37M	$410.71M	$315.39M	$327.92M
Net Income	$1.17B	$1.49B	$1.42B	$1.28B
Net Income Ratio	$0.18	$0.21	$0.21	$0.19
EPS	$0.64	$0.82	$0.78	$0.71
Diluted EPS	$0.64	$0.82	$0.78	$0.71
Weighted Avg Shares Outstanding	$1.82B	$1.82B	$1.82B	$1.82B
Weighted Avg Shares Outstanding (Diluted)	$1.82B	$1.82B	$1.82B	$1.82B

The United Laboratories International Holdings Limited